Markham-Based Astellas Oncology C3 Prize® Returns for Third Year with Focus on Improving Cancer Care in Underserved Regions of the World

MARKHAM, ON, June 12, 2018 /CNW/ - Astellas Pharma Canada, Inc. (APCA), the Canadian subsidiary of Tokyo based Astellas Pharma, Inc., today announced the launch of the third annual Astellas Oncology C3 Prize® (Changing Cancer Care), a global challenge aimed at inspiring non-treatment ideas that may improve cancer care for patients and their loved ones.

Categorized in: Business, Life Sciences & Health Technology Posted on: June 13, 2018 Last updated on: December 22, 2022 Written by: Nathan Allen

MARKHAM, ON, June 12, 2018 /CNW/ – Astellas Pharma Canada, Inc. (APCA), the Canadian subsidiary of Tokyo based Astellas Pharma, Inc., today announced the launch of the third annual Astellas Oncology C3 Prize® (Changing Cancer Care), a global challenge aimed at inspiring non-treatment ideas that may improve cancer care for patients and their loved ones. This year’s challenge will focus on solutions for cancer care in low- and middle-income countries, which bear a disproportionate burden of the global cancer epidemic.

Full Article: newswire.ca